Sprint Bioscience (Sweden) Market Value
| SPRINT Stock | SEK 0.73 0.53 42.06% |
| Symbol | Sprint |
Sprint Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sprint Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sprint Bioscience.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Sprint Bioscience on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Sprint Bioscience AB or generate 0.0% return on investment in Sprint Bioscience over 90 days. Sprint Bioscience is related to or competes with Cantargia, Saniona AB, Acarix AS, and Lidds AB. Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism More
Sprint Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sprint Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sprint Bioscience AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 17.57 | |||
| Value At Risk | (7.65) | |||
| Potential Upside | 5.92 |
Sprint Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sprint Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sprint Bioscience's standard deviation. In reality, there are many statistical measures that can use Sprint Bioscience historical prices to predict the future Sprint Bioscience's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | 1.2 |
Sprint Bioscience Backtested Returns
Sprint Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16 % return per unit of risk over the last 3 months. Sprint Bioscience AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sprint Bioscience's Risk Adjusted Performance of (0.13), variance of 38.25, and Coefficient Of Variation of (621.30) to confirm the risk estimate we provide. The entity has a beta of -0.84, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sprint Bioscience are expected to decrease at a much lower rate. During the bear market, Sprint Bioscience is likely to outperform the market. At this point, Sprint Bioscience has a negative expected return of -1.06%. Please make sure to validate Sprint Bioscience's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Sprint Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Sprint Bioscience AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Sprint Bioscience time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sprint Bioscience price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Sprint Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Sprint Bioscience lagged returns against current returns
Autocorrelation, which is Sprint Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sprint Bioscience's stock expected returns. We can calculate the autocorrelation of Sprint Bioscience returns to help us make a trade decision. For example, suppose you find that Sprint Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sprint Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sprint Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sprint Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sprint Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Sprint Bioscience Lagged Returns
When evaluating Sprint Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sprint Bioscience stock have on its future price. Sprint Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sprint Bioscience autocorrelation shows the relationship between Sprint Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Sprint Bioscience AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Sprint Stock
Sprint Bioscience financial ratios help investors to determine whether Sprint Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sprint with respect to the benefits of owning Sprint Bioscience security.